Why Has Japan Failed to Escape from Deflation?

Publisher： John Wiley & Sons Inc

E-ISSN： 1748-3131|13|1|23-41

ISSN： 1832-8105

Source： ASIAN ECONOMIC POLICY REVIEW, Vol.13, Iss.1, 2018-01, pp. : 23-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comment on “Why Has Japan Failed to Escape from Deflation?”

By  

ASIAN ECONOMIC POLICY REVIEW, Vol. 13, Iss. 1, 2018-01 ,pp. : 44-45

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comment on “Why Has Japan Failed to Escape from Deflation?”

By  

ASIAN ECONOMIC POLICY REVIEW, Vol. 13, Iss. 1, 2018-01 ,pp. : 42-43

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serono's somatropin [`Serostim'] has again failed to win approval from the European Commission's CPMP

By  

Inpharma, Vol. 1, Iss. 1405, 2003-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Since Novartis' COX-2 inhibitor lumiracoxib [`Prexige'] has failed to demonstrate features differentiating it from the class leader celecoxib [`Celebrex; Pfizer/Pharmacia'], it could have limited market success

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 403, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

A curriculum for SHO training – what is it and why has it changed?

By Carty E   Neville E   Pembroke M A   Wade W B  

Clinical Medicine, Vol. 1, Iss. 1, 2001-01 ,pp. : 50-53

Royal College Of Physicians

Access to resources Recommend Favorite